STOCK TITAN
  1. Home
  2. Sec-filings
  3. GTBP
  4. [EFFECT] GT Biopharma Inc. SEC Filing

[EFFECT] GT Biopharma Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 5:00 P.M.
Form: S-1
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-287963

Source: View Original Filing on SEC EDGAR

Stock GTBP logo
Gt Biopharma Inc

NASDAQ:GTBP

GTBP Rankings

#10122 Ranked by Market Cap
N/A Ranked by Dividends

GTBP Latest News

Jun 13, 2025
GT Biopharma Appoints New Member to its Board of Directors
May 19, 2025
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
May 15, 2025
GT Biopharma Appoints New Member to its Board of Directors
May 14, 2025
GT Biopharma Appoints New Member to its Board of Directors
Mar 4, 2025
GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit

GTBP Latest SEC Filings

Jul 3, 2025
[424B3] GT Biopharma Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 27, 2025
[S-1/A] GT Biopharma Inc. Amends IPO Registration Statement

GTBP Stock Data

11.96M
2.42M
18.13%
48.98%
11.2%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO